Review
doi: 10.1038/nrd773.
Protein kinases--the major drug targets of the twenty-first century?
Affiliations
- PMID: 12120282
- DOI: 10.1038/nrd773
Item in Clipboard
Review
Protein kinases--the major drug targets of the twenty-first century?
Nat Rev Drug Discov.
2002 Apr.
Abstract
Protein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease. A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clinical use. Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors. Here, I give a personal view of some of the most important advances that have shaped this field.
Similar articles
-
Protein kinase inhibitors as a therapeutic modality.Acc Chem Res. 2003 Jun;36(6):462-9. doi: 10.1021/ar0201207. Acc Chem Res. 2003. PMID: 12809533 Review.
-
Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.N Engl J Med. 2001 Apr 5;344(14):1084-6. doi: 10.1056/NEJM200104053441409. N Engl J Med. 2001. PMID: 11287980 No abstract available.
-
[Tyrosine kinase inhibitor STI571: new possibility in the treatment of chronic myeloid leukemia].Orv Hetil. 2002 Oct 20;143(42):2379-84. Orv Hetil. 2002. PMID: 12440260 Review. Hungarian.
-
Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.Circulation. 2004 Mar 16;109(10):1196-205. doi: 10.1161/01.CIR.0000118538.21306.A9. Circulation. 2004. PMID: 15023894 Review.
-
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.Oncogene. 2002 Dec 9;21(56):8541-6. doi: 10.1038/sj.onc.1206081. Oncogene. 2002. PMID: 12476300 Review. No abstract available.
Cited by
-
Metabolite concentrations, fluxes and free energies imply efficient enzyme usage.Nat Chem Biol. 2016 Jul;12(7):482-9. doi: 10.1038/nchembio.2077. Epub 2016 May 2. Nat Chem Biol. 2016. PMID: 27159581 Free PMC article.
-
Identification of Potential Inhibitors of Calcium/Calmodulin-Dependent Protein Kinase IV from Bioactive Phytoconstituents.Oxid Med Cell Longev. 2020 Jul 16;2020:2094635. doi: 10.1155/2020/2094635. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32724490 Free PMC article.
-
A Comparative Analysis and Review of lysyl Residues Affected by Posttranslational Modifications.Curr Genomics. 2015 Apr;16(2):128-38. doi: 10.2174/1389202916666150216221038. Curr Genomics. 2015. PMID: 26085811 Free PMC article.
-
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).Bioorg Med Chem Lett. 2009 Dec 1;19(23):6700-5. doi: 10.1016/j.bmcl.2009.09.121. Epub 2009 Oct 3. Bioorg Med Chem Lett. 2009. PMID: 19837585 Free PMC article.
-
Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors.RSC Adv. 2020 May 27;10(34):20129-20137. doi: 10.1039/d0ra00453g. eCollection 2020 May 26. RSC Adv. 2020. PMID: 35520423 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
